Key developments in rheumatology.
Bacon
P A
PA
Department of Rheumatology, Faculty of Medicine, University of Birmingham.
Allen
M
M
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D000906:Antibodies / Q000627:therapeutic use; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D012216:Rheumatic Diseases / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000906:Antibodies; D016861:Cyclooxygenase Inhibitors; D014409:Tumor Necrosis Factor-alpha